ES2039292T3 - Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden. - Google Patents

Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden.

Info

Publication number
ES2039292T3
ES2039292T3 ES198989101958T ES89101958T ES2039292T3 ES 2039292 T3 ES2039292 T3 ES 2039292T3 ES 198989101958 T ES198989101958 T ES 198989101958T ES 89101958 T ES89101958 T ES 89101958T ES 2039292 T3 ES2039292 T3 ES 2039292T3
Authority
ES
Spain
Prior art keywords
compounds
preparation
pyranobenzoxadiazole
derivatives
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198989101958T
Other languages
English (en)
Inventor
Kiyotomo Cno Nissan Chemical Ind. Ltd. Seto
Hiroo Cno Nissan Chemical Ind. Ltd. Matsumoto
Ltd. Kamikawaji Yoshimasa Cno Nissan Chemical Ind.
Kazuhiko Cno Nissan Chemical Ind. Ltd. Ohrai
Kyoko Cno Nissan Chemical Ind. Ltd. Nakayama
Ryozo Cno Nissan Chemical Ind. Ltd. Sakoda
Yukinori Cno Nissan Chemical Ind. Ltd. Bi Masuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Application granted granted Critical
Publication of ES2039292T3 publication Critical patent/ES2039292T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

LA INVERSION INCLUYE COMPUESTOS DE LA FORMULA (I): DONDE SE DESCRIBE LO QUE SE REPRESENTAN A, B, R EXP 4 Y R (AL CUADRADO) , SALES FARMACOLOGICAMENTE ACEPTABLES DE LOS COMPUESTOS QUE PUEDEN FORMAR SALES, METODOS PARA SU PREPARACION, USO FARMACEUTICO DE LOS COMPUESTOS Y COMPOSICIONES QUE INCLUYEN ESOS COMPUESTOS.
ES198989101958T 1988-02-03 1989-02-03 Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden. Expired - Lifetime ES2039292T3 (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2340988 1988-02-03
JP4845888 1988-03-01
JP7576288 1988-03-29
JP12758488 1988-05-25

Publications (1)

Publication Number Publication Date
ES2039292T3 true ES2039292T3 (es) 1993-09-16

Family

ID=27457958

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198989101958T Expired - Lifetime ES2039292T3 (es) 1988-02-03 1989-02-03 Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden.

Country Status (17)

Country Link
US (1) US4900752A (es)
EP (1) EP0327127B1 (es)
JP (1) JPH0699439B2 (es)
KR (1) KR970009591B1 (es)
AU (1) AU609244B2 (es)
BG (1) BG50159A3 (es)
BR (1) BR8905292A (es)
CA (1) CA1331990C (es)
DE (1) DE68900210D1 (es)
DK (2) DK167533B1 (es)
ES (1) ES2039292T3 (es)
FI (1) FI90240C (es)
GR (1) GR3002637T3 (es)
HU (1) HU206117B (es)
RU (1) RU2054007C1 (es)
WO (1) WO1989007103A1 (es)
ZA (1) ZA89860B (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
GB8924373D0 (en) * 1989-10-30 1989-12-20 Beecham Group Plc Novel compounds
DE4010097A1 (de) * 1990-03-29 1991-10-02 Basf Ag Ungesaettigte n-benzoxodiazolopyranyllactame, ihre herstellung und verwendung
JPH04342591A (ja) * 1990-07-10 1992-11-30 Nissan Chem Ind Ltd ピラノベンゾオキサジアゾール誘導体
US5164509A (en) * 1990-11-26 1992-11-17 E. R. Squibb & Sons, Inc. Benzodiazolo analogs
EP0492391A3 (en) * 1990-12-26 1993-01-20 Nissan Chemical Industries Ltd. Hair growth stimulator
CA2061179A1 (en) * 1991-02-18 1992-08-19 Ryuji Tsuzuki Oxzazinobenzazole compounds
US5352814A (en) * 1991-08-30 1994-10-04 Nissan Chemical Industries, Ltd. Asymmetric epoxidation reaction
WO1994022442A1 (en) * 1993-04-02 1994-10-13 Nissan Chemical Industries, Ltd. Heart failure remedy
KR101085979B1 (ko) * 2004-03-23 2011-11-22 닛산 가가쿠 고교 가부시키 가이샤 항부정맥제로 사용되는 삼환계 벤조피란 화합물
GB0615670D0 (en) * 2006-08-07 2006-09-13 Syngenta Participations Ag Chemical compounds
KR20120102050A (ko) 2009-10-06 2012-09-17 케이비아이 바이오파마, 인크. 입자를 조작하는 방법, 시스템 및 장치

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH25238A (fr) * 1901-10-22 1903-04-30 Fredinand Rozes Jean Nouvelle chaufferette
FR1406106A (fr) * 1963-04-10 1965-07-16 Daiichi Seiyaku Co Procédé de production de composés stéroïdes du [2, 3-c]-furazane
JPS5912738Y2 (ja) * 1979-04-20 1984-04-17 オリンパス光学工業株式会社 電源接続装置
DE3064285D1 (en) * 1979-09-28 1983-08-25 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
EP0028064B1 (en) * 1979-09-28 1983-07-20 Beecham Group Plc Chromanol derivatives, a process for their preparation and a pharmaceutical composition comprising them
EP0033612B1 (en) * 1980-02-02 1984-04-11 Beecham Group Plc Pyrano derivatives, a process for their preparation and antihypertensive compositions containing them
ZM7682A1 (en) * 1981-09-25 1983-05-23 Beecham Group Plc Active compounds

Also Published As

Publication number Publication date
BG50159A3 (en) 1992-05-15
JPH0699439B2 (ja) 1994-12-07
HU206117B (en) 1992-08-28
DK486089D0 (da) 1989-10-03
DE68900210D1 (de) 1991-09-26
HU891051D0 (en) 1990-03-28
JPH0249788A (ja) 1990-02-20
KR900700487A (ko) 1990-08-13
FI90240B (fi) 1993-09-30
EP0327127A1 (en) 1989-08-09
DK486089A (da) 1989-12-01
AU2963389A (en) 1989-08-03
BR8905292A (pt) 1990-08-21
DK169924B1 (da) 1995-04-03
DK167533B1 (da) 1993-11-15
ZA89860B (en) 1989-10-25
FI894520A (fi) 1989-09-25
FI90240C (fi) 1994-01-10
GR3002637T3 (en) 1993-01-25
US4900752A (en) 1990-02-13
CA1331990C (en) 1994-09-13
HUT56373A (en) 1991-08-28
EP0327127B1 (en) 1991-08-21
DK1693A (da) 1993-01-07
AU609244B2 (en) 1991-04-26
FI894520A0 (fi) 1989-09-25
DK1693D0 (da) 1993-01-07
WO1989007103A1 (en) 1989-08-10
KR970009591B1 (ko) 1997-06-14
RU2054007C1 (ru) 1996-02-10

Similar Documents

Publication Publication Date Title
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
MX9206305A (es) Bifenilpiridonas substitutas, procedimiento para su obtencion y medicamento que los contiene.
ES2058527T3 (es) Derivados de pirimidina condensados procedimiento y compuestos intermedios para su preparacion y composiciones farmaceuticas que los contienen.
UY24555A1 (es) Nuevos compuestos
ES2095432T3 (es) Derivados de 2,4-tiazolidin-diona, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
AR008630A1 (es) Indol-3-glioxilamidas n-sustituidas con efecto antiasmatico, antialergico e inmunosupresor/inmunomodulador, procedimientos para su preparacion, suutilizacion farmaceutica y las composiciones farmaceuticas que las contienen.
MX9300498A (es) Derivados de n-sulfonil-2-oxo-indol, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
YU47116B (sh) Postupak za dobijanje novih n-supstituisanih benzimidazolskih derivata
AR021355A1 (es) Derivados de quinolina. procedimiento para su preparacion, composicion farmaceutica que los comprende, y el uso de los mismos para la fabricacion de unmedicamento
IL94433A0 (en) Aminophenol derivatives,their preparation and pharmaceutical compositions containing them
ES2039292T3 (es) Derivados de piranobenzoxadiazol, preparacion de los mismos, utilizacion y compuestos que los comprenden.
MX9204637A (es) Nuevos derivados de pirazina y procedimiento para su preparacion.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
ECSP941120A (es) Derivados de 1,5 benzodiazepina
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
MX9300628A (es) Nuevos derivados de taxano, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2091310T3 (es) Nuevos derivados de la n-benzoil-prolina, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
MX9301157A (es) Derivados de bencimidazolona, procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
AR002017A1 (es) Derivados de fenil-4-tiazoles substituidos, procedimiento para su preparacion, composiciones farmaceuticas que los contienen y derivados defenil-4-tiazoles substituidos empleados en dicho procedimiento.
MX9400165A (es) Derivados de ter-butilergolina, proceso para su produccion y composiciones farmaceuticas que los contienen.
AR007052A1 (es) Un derivado de carbohidrato, su uso y una composicion farmaceutica que lo comprende
IT1197516B (it) Derivati teofillinmetilanici e teofillinmetilditianici procedimento per la loro preparazione e composizioni farmaceutiche che li comprendono
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
MX9303574A (es) Compuestos heterociclicos que son inhibidores de la enzima aromatasa, proceso para su preparacion ycomposiciones farmaceuticas que los contienen.
ES2182090T3 (es) Nuevos derivados de pirrol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 327127

Country of ref document: ES